Non-Hodgkin's Lymphoma in Patients With Human Immunodeficiency Virus Infection in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 4, 2010, Pages 278-284

  Yang, Chia Jui ^a   Chen, Mao Yuan ^b   Hsieh, Szu Min ^b   Sheng, Wang Huei ^b   Sun, Hsin Yun ^b   Hung, Chien Ching ^b   Chang, Shan Chwen ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AIDS; HIV; Non Hodgkin's lymphoma; Taiwan

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MEDICAL RECORD REVIEW; NONHODGKIN LYMPHOMA; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TAIWAN; TREND STUDY; AGED; COMPLICATION; HIV INFECTIONS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAIWAN;

EID: 77955315169     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60044-8     Document Type: Article

References (26)

1. Wood C, Harrington W AIDS and associated malignancies. Cell Res 2005, 15:947-952.
2. Frisch M, Biggar RJ, Engels EA, Goedert JJ Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001, 285:1736-1745.
3. Biggar RJ, Curtis RE, Cote TR, Rabkin CS, Melbye M Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994, 139:362-368.
4. Rabkin CS Epidemiology of AIDS-related malignancies. Curr Opin Oncol 1994, 6:492-496.
5. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002, 94:1204-1210.
6. Centers for Disease Control; Atlanta, Georgia. Revision of the case definition of acquired immunodeficiency syndrome for national reporting. MMWR Morb Mortal Wkly Rep 1985, 34:373-375.
7. Biggar RJ, Rabkin CS The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996, 10:997-1010.
8. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000, 92:1823-1830. International Collaboration on HIV and Cancer.
9. Hentrich M, Maretta L, Chow KU, Bogner JR, Schürmann D, Neuhoff P, et al. Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Ann Oncol 2006, 17:914-919.
10. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the united states in the era of highly active antiretroviral therapy. Clin Infect Dis 2000, 30(Suppl 1):S5-14.
11. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV cohort study. JAMA 1999, 282:2220-2226.
12. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998, 338:853-860.
13. Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med 2008, 9:535-543.
14. Hung CC, Hsiao CF, Chen MY, Hsieh SM, Chang SY, Sheng WH, et al. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006, 59:222-228.
15. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000, 24:378-385.
16. A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993, 329:987-994.
17. Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, Hsiao CF, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis 2006, 59:311-316.
18. Forrest DM, Seminari E, Hogg RS, Yip B, Raboud J, Lawson L, et al. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis 1998, 27:1379-1385.
19. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA study group. Lancet 1998, 352:1725-1730.
20. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active anti-retroviral therapy. Blood 2000, 96:2730-2734.
21. Palmieri C, Treibel T, Large O, Bower M AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiret-roviral therapy. QJM 2006, 99:811-826.
22. Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005, 39:293-299.
23. Powles T, Imami N, Nelson M, Gazzard BG, Bower M Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002, 16:531-536.
24. Bonnet F, Balestre E, Thiebaut R, Morlat P, Pellegrin JL, Neau D, et al. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretro-viral therapy: Aquitaine cohort, France. Clin Infect Dis 2006, 42:411-417.
25. Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 2005, 23:8477-8482.
26. Bower M, Gazzard B, Mandalia S, Newsom-Davis T, Thirlwell C, Dhillon T, et al. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med 2005, 143:265-273.